Cancer research
Researchers from the Islamic University of Science and Technology have made a significant contribution to the field of oncology with their innovative approach to diagnosing esophageal cancer. By leveraging deep learning analysis of digital pathological imagery data, the researchers have developed a framework that can predict metastatic potential and identify
Cancer research
A study published in Scientific Reports has found that adjuvant radiotherapy (RT) does not improve long-term survival in elderly male breast cancer patients treated with breast-conserving surgery (BCS). The research, conducted using the Surveillance, Epidemiology, and End Results (SEER) database, included 360 patients with early-stage, low-risk breast cancer (node-negative, hormone
Cancer research
Research conducted by University of Campania Luigi Vanvitelli has found a significant link between metabolic dysfunction, type 2 diabetes mellitus (T2DM), and primary liver cancer (PLC). According to the study, individuals with T2DM and metabolic dysfunction-associated steatotic liver disease (MASLD) are at a higher risk of developing PLC. The researchers
Cancer research
Research conducted by Kyung Hee University in Seoul, South Korea, has investigated the effectiveness of colistin therapy in cancer patients with multidrug-resistant Gram-negative bacterial (MDR GNB) infections. The study, published in Medicina, aimed to evaluate the mortality risk associated with colistin versus non-colistin regimens in cancer patients with MDR GNB
Cancer
Researchers have detailed new data in venous thromboembolism, highlighting the risks associated with cancer-related venous thromboembolism (VTE). According to the study, patients with cancer-associated VTE are at increased risk of both recurrent VTE and bleeding, with the magnitude of this variation remaining unclear. The study aimed to compare the 90-day
Cancer research
A Phase 3 clinical trial has been initiated by the University of Birmingham to investigate the efficacy of apixaban in preventing blood clots in lung cancer patients undergoing systemic anticancer treatment. The trial aims to enroll a sample of 1456 participants from the USA and will be led by principal
Cancer
Pediatric hematology oncology providers are interested in learning more about acupuncture as a symptom management tool for their patients with cancer, despite being reluctant to recommend it due to a lack of robust data in the pediatric oncology population. A cross-sectional survey of 78 providers at a US pediatric cancer
Cancer
Sir Chris Hoy, the retired track cyclist and Scotland's most successful Olympian, has launched a fitness partnership with PureGym, the Institute of Cancer Research, and the Royal Marsden NHS Foundation Trust to support men living with late-stage prostate cancer. The partnership offers free, one-year gym memberships to men
Cancer research
A recent study published in Pancreas, a journal of the Lippincott Williams & Wilkins, has shed light on the clinical characteristics and risk factors for stroke in patients with unresectable pancreatic cancer receiving chemotherapy. The research, conducted by a team of researchers from Kurashiki Central Hospital in Japan, involved a
Cancer research
Researchers at Sun Yat-sen University have found that overexpression of protein kinase C iota (PKCi) is associated with tumor aggressiveness and chemotherapy resistance in patients with colorectal cancer. In a retrospective analysis of patients with confirmed cancer diagnoses, the team found that PKCi overexpression was correlated with advanced clinical stage,
Cancer
A significant proportion of older adults suffer from chronic non-cancer pain, with estimates ranging from 28% to 88% of the population experiencing persistent pain. These individuals often face medication-related problems and receive inadequate pain therapy, compromising their quality of care. Researchers from the University of Applied Sciences and Arts Western
Cancer research
A study published in European Urology Open Science has made significant findings in the realm of penile cancer, indicating that certain biomarkers can serve as indicators for prognosis and treatment. Researchers at Orebro University in Sweden examined the expression of programmed cell death ligand 1 (PD-L1), T-cell immunoglobulin and immunoreceptor
